Amodiaquine/Artesunate

阿莫地喹/青蒿琥酯

Report date: 2022/03/22 11:18:39

Base Information

Drug NameAmodiaquine/Artesunate
Drug Alias NameArtesunic acid and Amodiaquine青蒿琥酯/阿莫地喹Artesunic acid/Amodiaquine青蒿琥酯阿莫地喹Amodiaquine/Artesunic acid +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsMalaria
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAfrica
Original Approved Date2007/01/01
Country/TerritoryAfricaUgandaSenegal +[8] 
CombinationsYes ArtesunateAmodiaquine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDrugs For Neglected Diseases Initiative (Dndi) Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoSanofiHeidelberg University +[5] 
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeP01BF03
Related LinksN/A